Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core

doi:10.1007/s00213-013-3082-0

Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core

Communities & Collections

pcg.skipToMenu

Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core

View Usage Statistics

Bibliographic description

punktacja MEiN [2013 A]: 35

title:	Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core
author:	Wickham Robert J., Solecki Wojciech , Rathbun Liza, McIntosh J. Michael, Addy Nii A.
journal title:	Psychopharmacology
volume:	229
issue:	1
date of publication :	2013
pages:	73-82
ISSN:	0033-3158
eISSN:	1432-2072
DOI:	10.1007/s00213-013-3082-0
URL:	http://link.springer.com/article/10.1007/s00213-013-3082-0/fulltext.html
date accessed:	2014-09-24
language:	English
journal language:	English
abstract in English:	Phasic dopamine (DA) signaling underlies reward learning. Cholinergic and glutamatergic inputs into the ventral tegmental area (VTA) are crucial for modulating burst firing activity and subsequent phasic DA release in the nucleus accumbens (NAc), but the specific VTA nicotinic receptor subtypes that regulate phasic DA release have not been identified. The goal was to determine the role of VTA N-methyl-d-aspartate receptors (NMDARs) and specific subtypes of nicotinic acetylcholine receptors (nAChRs) in regulating phasic DA release in the NAc core. Fast-scan cyclic voltammetry in anesthetized rats was combined with intra-VTA micro-infusion to evaluate the ability of glutamatergic and cholinergic drugs to modulate stimulated phasic DA release in the NAc core. VTA NMDAR blockade with AP-5 decreased, while VTA NMDAR activation with NMDA increased NAc peak phasic DA release. Intra-VTA administration of the nonspecific nAChR antagonist mecamylamine produced a persistent decrease in phasic DA release. Infusion of the α6-selective antagonist α-conotoxin MII (α-ctx MII) produced a robust, but transient decrease in phasic DA, whereas infusion of selective doses of either the α4β2-selective antagonist, dihydro-beta-erythroidine, or the α7 antagonist, methyllycaconitine, had no effect. Co-infusion of AP-5 and α-ctx MII produced a similar phasic DA decrease as either drug alone, with no additive effect. The results suggest that VTA α6β2 nAChRs, but not α4β2 or α7 nAChRs, regulate phasic DA release in the NAc core and that VTA α6β2 nAChRs and NMDA receptors act at a common site or target to regulate NAc phasic DA signaling.
keywords in English:	Dopamine-Nicotinic, receptor-NMDA, receptor-Fast-scancyclic, voltammetry-Ventral tegmental, area-Nucleus accumbens
number of pulisher's sheets:	0,5
type:	journal article
subtype:	academic paper

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Publikacje naukowe